OAC
SGMT icon

OMERS Administration Corp’s Sagimet Biosciences SGMT Stock Holding History

OMERS Administration Corp’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41,100
Closed -$215K – 1110
2026
Q1 		$215K Sell
41,100
-12,300
-23% -$68.6K ﹤0.01% 901
2025
Q4 		$316K Buy
+53,400
New +$384K ﹤0.01% 798
2025
Q2 		– Sell
-85,600
Closed -$279K – 1072
2025
Q1 		$279K Buy
85,600
+27,100
+46% +$114K ﹤0.01% 872
2024
Q4 		$263K Buy
+58,500
New +$296K ﹤0.01% 840

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

OMERS Administration Corp's SGMT Position: Q2 2026 in Review

OMERS Administration Corp sold out of Sagimet Biosciences (SGMT) in Q2 2026, closing a stake of 41,100 shares — an estimated $215K sold.

OMERS Administration Corp first reported a position in SGMT in Q4 2024 and held it in 4 quarters. The position peaked at $316K in Q4 2025. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • OMERS Administration Corp reported no remaining Sagimet Biosciences position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 41,100 Sagimet Biosciences shares in Q2 2026, an estimated $215K.
  • OMERS Administration Corp first reported a position in Sagimet Biosciences in Q4 2024 and held it in 4 quarters.
  • OMERS Administration Corp's Sagimet Biosciences position peaked at $316K in Q4 2025.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.